Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PeRsOnalising Treatment Of Diabetic Nephropathy: From Albuminuria to Multidimensional Characterisation of Diabetic Nephropathy - a Cross-sectional Study

NCT03509454 is registered in ClinicalTrials.gov with Peter Rossing as lead sponsor.

NCT NCT03509454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03509454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PeRsOnalising Treatment Of Diabetic Nephropathy: From Albuminuria to Multidimensional Characterisation of Diabetic Nephropathy - a Cross-sectional Study
Lead sponsor
Peter Rossing
Phase
Observational
Overall status
Completed
Start date
April 1, 2016
Completion date
April 1, 2018
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes complications, diabetes mellitus, type 1, diabetic nephropathies